메뉴 건너뛰기




Volumn 9, Issue 9, 2010, Pages 1135-1138

Hyaluronic acid filler and botulinum neurotoxin delivered simultaneously in the same syringe for effective and convenient combination aesthetic rejuvenation therapy

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BOTULINUM TOXIN; BOTULINUM TOXIN A; HYALURONIC ACID; LIDOCAINE; BIOMATERIAL; MUSCLE RELAXANT AGENT;

EID: 77957949221     PISSN: 15459616     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (17)

References (14)
  • 2
    • 70349666911 scopus 로고    scopus 로고
    • Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: Double-blind, placebo-controlled, dose-ranging study
    • Ascher B, Rzany BJ, Grover R. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow's feet: Double-blind, placebo-controlled, dose-ranging study. Dermatol Surg. 2009;5:1478-1486.
    • (2009) Dermatol Surg , vol.5 , pp. 1478-1486
    • Ascher, B.1    Rzany, B.J.2    Grover, R.3
  • 3
    • 71549130229 scopus 로고    scopus 로고
    • Evaluation of variable-dose treatment with a new US botulinum toxin type A (Dysport) for correction of moderate to severe glabellar lines: Results from a phase 3, double-blind, placebo-controlled study
    • Kane MA, Brandt F, Rohrich RJ, et al. Evaluation of variable-dose treatment with a new US botulinum toxin type A (Dysport) for correction of moderate to severe glabellar lines: Results from a phase 3, double-blind, placebo-controlled study. Plast Reconstr Surg. 2009;124(5):1619-1629.
    • (2009) Plast Reconstr Surg , vol.124 , Issue.5 , pp. 1619-1629
    • Kane, M.A.1    Brandt, F.2    Rohrich, R.J.3
  • 4
    • 63149109494 scopus 로고    scopus 로고
    • Long term safety and efficacy of a new botulinum toxin type A in treating glabellar lines
    • Moy R, Maas C, Monheit G, et al. Long term safety and efficacy of a new botulinum toxin type A in treating glabellar lines. Arch Facial Plast Surg. 2009;11:77-83.
    • (2009) Arch Facial Plast Surg , vol.11 , pp. 77-83
    • Moy, R.1    Maas, C.2    Monheit, G.3
  • 5
    • 33745807295 scopus 로고    scopus 로고
    • Injectable hyaluronic acid implant for malar and mental enhancement
    • DOI 10.1111/j.1524-4725.2006.32190.x
    • Lowe N, Grover R. Injectable hyaluronic acid implant for malar and mental enhancement. Dermatol Surg. 2006;32(7):881-885. (Pubitemid 44034362)
    • (2006) Dermatologic Surgery , vol.32 , Issue.7 , pp. 881-885
    • Lowe, N.J.1    Grover, R.2
  • 6
    • 0043246550 scopus 로고    scopus 로고
    • A prospective, randomized, parallel group study analyzing the effect of BTX-A (botox) and nonanimal sourced hyaluronic acid (NASHA, restylane) in combination compared with NASHA (restylane) alone in severe glabellar rhytides in adult female subjects: Treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A
    • DOI 10.1046/j.1524-4725.2003.29212.x
    • Carruthers A, Carruthers J. A prospective, randomized, parallel group study analyzing the effect of BTX-A (Botox) and nonanimal sourced hyaluronic acid (NASHA, Restylane) in combination compared with NASHA (Restylane) alone in severe glabellar rhytides in adult female subjects: Treatment of severe glabellar rhytides with a hyaluronic acid derivative compared with the derivative and BTX-A. Dermatol Surg. 2003;29(8):802-809. (Pubitemid 36934437)
    • (2003) Dermatologic Surgery , vol.29 , Issue.8 , pp. 802-809
    • Carruthers, J.1    Carruthers, A.2
  • 7
    • 37348998912 scopus 로고    scopus 로고
    • Hyaluronic acid fillers and botulinum toxin type A: Rationale for their individual and combined use for injectable facial rejuvenation
    • DOI 10.1097/01.prs.0000248857.84859.07, PII 0000653420071100100012
    • Klein AW, Fagien S. Hyaluronic acid fillers and botulinum toxin type A: Rationale for their individual and combined use for Injectable facial rejuvenation. Plast Reconstr Surg. 2007;120(6 Suppl):81S-88S. (Pubitemid 350306747)
    • (2007) Plastic and Reconstructive Surgery , vol.120 , Issue.6 S SUPPL.
    • Klein, A.W.1    Fagien, S.2
  • 8
    • 74049102072 scopus 로고    scopus 로고
    • Hyaluronics for soft-tissue augmentation: Practical considerations and technical recommendations
    • Beer K, Solish, N. Hyaluronics for soft-tissue augmentation: Practical considerations and technical recommendations. J Drugs Dermatol. 2009;8(12):1086-1091.
    • (2009) J Drugs Dermatol , vol.8 , Issue.12 , pp. 1086-1091
    • Beer, K.1    Solish, N.2
  • 9
    • 77957655377 scopus 로고    scopus 로고
    • Expanding the use of neurotoxins in facial aesthetics: A consensus panel's assessment and recommendations
    • Kane M, Donofrio L, Ascher B, et al. Expanding the use of neurotoxins in facial aesthetics: A consensus panel's assessment and recommendations. J Drugs Dermatol. 2010;9(1 Suppl):S7-S22.
    • (2010) J Drugs Dermatol , vol.9 , Issue.1 SUPPL.
    • Kane, M.1    Donofrio, L.2    Ascher, B.3
  • 10
    • 71549146072 scopus 로고    scopus 로고
    • Randomized, placebo-controlled study of a new botulinum toxin type A for treatment of glabellar lines: Efficacy and safety
    • Brandt F, Swanson N, Baumann L, Huber B. Randomized, placebo-controlled study of a new botulinum toxin type A for treatment of glabellar lines: Efficacy and safety. Derm Surg. 2009;35:1893-1901.
    • (2009) Derm Surg , vol.35 , pp. 1893-1901
    • Brandt, F.1    Swanson, N.2    Baumann, L.3    Huber, B.4
  • 11
    • 85042586232 scopus 로고    scopus 로고
    • The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: Review and technical considerations
    • Rohrich R, Ghavami A, Crosby M. The role of hyaluronic acid fillers (Restylane) in facial cosmetic surgery: Review and technical considerations. Plast Reconstr Surg. 2007;120(6 suppl): 41S-54S.
    • (2007) Plast Reconstr Surg , vol.120 , Issue.6 SUPPL.
    • Rohrich, R.1    Ghavami, A.2    Crosby, M.3
  • 12
    • 46749121843 scopus 로고    scopus 로고
    • Evaluation of injectable CaHA for the treatment of mid-face volume loss
    • Beer K, Yohn M, Cohen JL. Evaluation of injectable CaHA for the treatment of mid-face volume loss. J Drugs Dermatol. 2008;7(4):359-366.
    • (2008) J Drugs Dermatol , vol.7 , Issue.4 , pp. 359-366
    • Beer, K.1    Yohn, M.2    Cohen, J.L.3
  • 13
    • 47249160751 scopus 로고    scopus 로고
    • Dermatological implications of skeletal aging: A focus on supraperiosteal volumization for perioral rejuvenation
    • Vleggaar D, Fitzgerald R. Dermatological implications of skeletal aging: A focus on supraperiosteal volumization for perioral rejuvenation. J Drugs Dermatol. 2008;7(3):209-220.
    • (2008) J Drugs Dermatol , vol.7 , Issue.3 , pp. 209-220
    • Vleggaar, D.1    Fitzgerald, R.2
  • 14
    • 77953625098 scopus 로고    scopus 로고
    • Localization and histological characterization of injected hyaluronic acid in excised nasolabial fold tissue
    • Greco TM, Elenitsas R. Localization and histological characterization of injected hyaluronic acid in excised nasolabial fold tissue. J Drugs Dermatol. 2010;9(4):399-404.
    • (2010) J Drugs Dermatol , vol.9 , Issue.4 , pp. 399-404
    • Greco, T.M.1    Elenitsas, R.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.